Dr
Andrew
Wells

Partner & Head of Chemistry

Manchester Office

Chemistry

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 752 507 1499
Email. [email protected]

Experience

Andrew’s patent practice is principally in the pharmaceutical and chemical fields. He has extensive experience in securing patent protection for pharmaceuticals and specialises in drafting and prosecuting patent applications covering new chemical entities, salts, polymorphs, formulations (including advanced drug delivery technologies), manufacturing processes, medical uses, and medical devices. Outside of the pharmaceutical field, Andrew’s practice encompasses agrochemicals, polymer chemistry, petroleum additives, catalytic compositions, separation chemistry, adhesive technologies and biosensors.

Andrew acts for a diverse range of clients, including international corporations, universities, start-up companies and associate patent attorney firms based outside of the UK.

He commenced his patent career in private practice before joining the in-house patent department of a major multi-national pharmaceutical company in June 2004. As an in-house attorney, Andrew was responsible for the patent portfolios relating to a number of high priority drug development projects, as well as conducting IP due diligence evaluations to support in-licensing activities. Andrew returned to private practice in November 2008 when he joined the Manchester office of HGF as a Partner.

Andrew draws on both his private practice and in-house experience to provide commercially-focused advice to his clients in relation to all patent matters, including patent portfolio management, enforcing patent rights, challenging third party patent rights, providing infringement and validity opinions, and conducting due diligence evaluations to support licensing and acquisition deals. Andrew also has considerable experience in representing clients in opposition and appeal proceedings at the European Patent Office.

Specialisms

  • Catalysis
  • Food science
  • Material science
  • Petrochemicals
  • Pharmaceutical technologies
  • Polymer chemistry

Industries

  • Agrochemicals icon Agrochemicals
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • In-house legal support
  • Patent oppositions & appeals
  • Patent term extensions & SPCs
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


OTHER

BPharm

PHD

The development and evaluation of microparticulate formulations for DNA immunisation

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate in Intellectual Property Law

Recognition

IAM Strategy 300 - Leading IP Strategists

Andrew is listed in the IAM Strategy 300 as a leading IP strategist

View recognition online

IAM Patent 1000

Andrew is listed in the IAM Patent 1000 as a leading IP attorney in his field.

View recognition online

MIP Star

Andrew is listed as a MIP Star.

View recognition online

Publications

IAM Strategy 300 2021

View publication online

Drug repurposing: progress, challenges and recommendations - Nature Medicine article on Drug Repurposing

View publication online

Conferences: 2021

October 7th 2021

The Business of Science Conference 2021

Attended

Event details

CSR

Andrew mentors and contributes to the professional training of Trainee Patent Attorneys within HGF, as well as mentoring and training of IP and technology transfer professionals in other organisations.

Related News

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Tarilian Laser Technologies - a case study in due diligence

When deciding whether to invest in a company, an investor will inevitably have to decide the value of the company. Taking a simplified view, a company’s valuation can be considered …

Read article

Health-conscious IP strategies

Strategies for navigating European patent portfolios in healthcare. Securing patent protection is critically important for innovative companies operating in the healthcare sector. European patent filings in healthcare, and particularly those …

Read article

Start-ups & IP, a case study: SleepCogni

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …

Read article
Event - 9th December 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …

Event details
Event - 1st December 2021

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …

Event details

Lab-grown meat – not yet on the menu

It is now eight years since the first lab-grown burger was unveiled by a team of scientists at Maastricht University, but since then the path to market has been slow. …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.